Deceptive pigment changes in neoadjuvant sonidegib therapy for basal cell carcinoma
British Journal of Dermatology · 14.08.2024 · 191 (3) · 472-473
DOI: 10.1093/bjd/ljae187 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Dermatology, online erschienen am 04.05.2024. Verfasst von Shenxi Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Neoadjuvant Therapy, Pyridines, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China.
- Key Laboratory of Molecular Diagnosis on Dermatoses; National Clinical Research Center for Skin and Immune Diseases; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.
ORCID-Profile: Shenxi Zhang, Menglong Ran
Zitieren
APA
Zhang, S., & Ran, M. (2024). Deceptive pigment changes in neoadjuvant sonidegib therapy for basal cell carcinoma. British Journal of Dermatology, 191(3), 472-473. https://doi.org/10.1093/bjd/ljae187
Vancouver
Zhang S, Ran M. Deceptive pigment changes in neoadjuvant sonidegib therapy for basal cell carcinoma. British Journal of Dermatology. 2024;191(3):472-473. doi:10.1093/bjd/ljae187
BibTeX
@article{Zhang2024,
author = {Zhang, Shenxi and Ran, Menglong},
title = {Deceptive pigment changes in neoadjuvant sonidegib therapy for basal cell carcinoma},
journal = {British Journal of Dermatology},
year = {2024},
volume = {191},
number = {3},
pages = {472--473},
doi = {10.1093/bjd/ljae187}
}
EUVIMED